Dapagliflozin and Saxagliptin Tablets (RLD Qtern) had estimated annual sales of US $5 million in the US
AMP-6 & AMP-8 are special purpose entities formed for purpose of setting up captive solar power projects in Karnataka
Elpiscience will receive up to US $37 million, including the upfront payment and license option fees
Loteprednol Etabonate Ophthalmic Suspension, 0.2%, is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis
The product is expected to be launched in December 2023
Funding round led by Sarissa Capital, includes Sun Pharma, Polaris Partners
Development services for gene and cell therapies is planned to begin first in 2025
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201
Clariant Healthcare highlighted Vitipure Meglumine LEX and VitiPure Superior at the recently concluded CPhI India
Subscribe To Our Newsletter & Stay Updated
